How a cholesterol drug may prevent heart attacks

A new study conducted at Cedars-Sinai reveals how the cholesterol-reducing drug evolocumab prevents heart attacks in people with coronary artery disease—a leading cause of death in the United States.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup